Results 121 to 130 of about 2,092 (196)

Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial. [PDF]

Front Pharmacol, 2023
Kalinin MN, Khasanova DR.
europepmc   +1 more source

Cost-effectiveness of Cerebrolysin as an add-on treatment for neurorecovery after traumatic brain injury. [PDF]

J Med Life
Strilciuc S, Grad DA, Vlădescu C, Buzoianu AD, Albu C, Mureșanu DF.   +5 more
europepmc   +1 more source

Influence of Exogenous Neuropeptides on the Astrocyte Response Under Conditions of Continuous and Cyclic Hypoxia and Red Blood Cell Lysate. [PDF]

Int J Mol Sci
Kojder K, Gąssowska-Dobrowolska M, Żwierełło W, Kłos P, Piotrowska K, Wszołek A, Maruszewska A, Gutowska I, Chlubek D, Baranowska-Bosiacka I.   +9 more
europepmc   +1 more source

Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study. [PDF]

J Med Life, 2023
Firstenfeld AJ, Listorti J, Jalaff N, Loaiza Orozco CP, Navarrete Gosdenovich F, Schurr T.   +5 more
europepmc   +1 more source

Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study. [PDF]

Stroke
Homberg V, Jianu DC, Stan A, Strilciuc Ș, Chelaru VF, Karliński M, Brainin M, Heiss WD, Muresanu DF, Enderby PM.   +9 more
europepmc   +1 more source

Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies. [PDF]

BMC Neurosci
Rockenstein E, Ubhi K, Mante M, Florio J, Adame A, Winter S, Brandstaetter H, Meier D, Masliah E.   +8 more
europepmc   +1 more source

Zum Mechanismus der Addison-Hypoglykaemie [PDF]

, 1969
Bottermann, P., Dieterle, P., Schwarz, K., Scriba, Peter Christian, Souvatzoglou, A.   +4 more
core   +1 more source

Conservative and newer drug treatment for degenerative cervical myelopathy. [PDF]

J Clin Orthop Trauma
Ede O, Cheung JPY.
europepmc   +1 more source

Pharmacological Management of Mild Cognitive Impairment: From Symptomatic Treatment to Disease Modification-A Narrative Review. [PDF]

NeuroSci
Mangalagiu AG, Petrescu BM, Riga S, Vasiliu O.   +3 more
europepmc   +1 more source

Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis. [PDF]

Alzheimers Dement
Masserini F, Gendarini C, Baso G, Salvadori E, Pantoni L.   +4 more
europepmc   +1 more source